Our analysis suggests an increased contribution of glutamate, rather than glutamine, to the TCA cycle in IDH1MUT glioma, by maintaining high expression levels of GLUD1/2 and silencing or downregulation of BCAT expression. The gene discussed is GLUD1; the disease is central nervous system cancer.